Trial intelligence / Profile preview

GW685698 vs Fluticasone Propionate in Seasonal Allergic Rhinitis

NCT00363740Phase 3Completed

Sponsor
GSK
Start
Feb 2005
Primary completion
Apr 2005
Modality
Orthosteric Ligands
01

Overview

A Phase 3 trial of fluticasone in seasonal allergic rhinitis (SAR), sponsored by GSK. Started Feb 2005; status: completed.

02

Drugs

fluticasone
03

Conditions

seasonal allergic rhinitis (SAR)

Beyond the preview

Go deeper on NCT00363740.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00363740.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call